Get 20% Free Customization In This Report

Buy this report from - $3456

Radiotherapy Simulators Market by Product (Multi-Slice Radiotherapy Simulators, Large Bore Radiotherapy Simulators, and others), By Application (Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostrate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer, and Other Applications), and By End Users (Hospitals, Clinics, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_182743	Pages: NA	Jun 2018 \| 759 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Radiotherapy simulators are the devices used to apply high energy particles or waves on target cells to destroy or stop the growth of the cells. Radiotherapy simulators are widely used for the treatment of cancer either by preventing recurrence of cancer or destroying tumor cells. The radiotherapy simulators may be invasive (internal radiation) or non-invasive (external radiation).

Increase in prevalence of cancer majorly drives the market growth. According to the American Cancer Society, the worldwide cancer cases are estimated to increase by 50% from 14 million to 21 million; from 2012 to 2030, respectively. In addition, increase in prevalence of thyroid diseases, blood disorder, and other diseases and rise in government and private organizations investments fuel the radiotherapy simulators market.

In addition, R&D in the field of radiotherapy simulators and lucrative opportunities in emerging economies is anticipated to create new opportunities during the forecast period. However, lack of skilled professions & infrastructure and incidence of adverse effects is expected to restrain the growth of the market during the forecast period.

The market is segmented on the basis of product, application, end user, and geography. Based on product, the market is divided into multi-slice radiotherapy simulators, large bore radiotherapy simulators, and others. Based on application, it is classified into skin & lip cancer, head & neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer, and other applications. Based on end user, it is categorized into hospitals, clinics and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the global radiotherapy simulators market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Radiotherapy Simulators Market Key Segments:

By Product

Multi-Slice Radiotherapy Simulators
Large Bore Radiotherapy Simulators
Others

By Application

Skin & Lip Cancer
Head & Neck Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Spine Cancer
Other Applications

By End-User

Hospitals
Clinics
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

List of players profiled in the report

GE Healthcare
Toshiba Medical Systems
Siemens Healthcare
Fluke Biomedical
Ziehm Imaging
Koninklijke Philips N.V.
Hologic, Inc.
Shimadzu Corporation
Huestis Machine Corp.
Modus Medical Devices Inc.

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 RADIOTHERAPY SIMULATORS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MULTI-SLICE RADIOTHERAPY SIMULATORS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. LARGE BORE RADIOTHERAPY SIMULATORS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. OTHERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 RADIOTHERAPY SIMULATORS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SKIN & LIP CANCER

5.2.1. Market size and forecast

5.3. HEAD & NECK CANCER

5.3.1. Market size and forecast

5.4. BREAST CANCER

5.4.1. Market size and forecast

5.5. PROSTRATE CANCER

5.5.1. Market size and forecast

5.6. CERVICAL CANCER

5.6.1. Market size and forecast

5.7. LUNG CANCER

5.7.1. Market size and forecast

5.8. SPINE CANCER

5.8.1. Market size and forecast

5.9. OTHER APPLICATIONS

5.9.1. Market size and forecast

Chapter: 6 RADIOTHERAPY SIMULATORS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. CLINICS

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

Chapter: 7 RADIOTHERAPY SIMULATORS MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Radiotherapy Simulators Market by Product
7.2.5. North America Radiotherapy Simulators Market by Application
7.2.6. North America Radiotherapy Simulators Market by End-User

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Radiotherapy Simulators Market by Product
7.3.5. Europe Radiotherapy Simulators Market by Application
7.3.6. Europe Radiotherapy Simulators Market by End-User

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Radiotherapy Simulators Market by Product
7.4.5. Asia-Pacific Radiotherapy Simulators Market by Application
7.4.6. Asia-Pacific Radiotherapy Simulators Market by End-User

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Latin America market size and forecast
7.5.3.2. Middle East market size and forecast
7.5.3.3. Africa market size and forecast

7.5.4. LAMEA Radiotherapy Simulators Market by Product
7.5.5. LAMEA Radiotherapy Simulators Market by Application
7.5.6. LAMEA Radiotherapy Simulators Market by End-User

Chapter: 8 COMPANY PROFILES

8.1. GE HEALTHCARE

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. TOSHIBA MEDICAL SYSTEMS

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.3. SIEMENS HEALTHCARE

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. FLUKE BIOMEDICAL

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. ZIEHM IMAGING

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. KONINKLIJKE PHILIPS N.V.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. HOLOGIC, INC

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. SHIMADZU CORPORATION

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. HUESTIS MACHINE CORP.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. MODUS MEDICAL DEVICES INC.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.